Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic Polymorphisms of Very Important Pharmacogene Variants in the Blang Population from Yunnan Province in China. | Pharmgenomics Pers Med | 2021 | 34949935 | PubTator, text mining | PubMed |
| Drug-Drug Interactions in Vestibular Diseases, Clinical Problems, and Medico-Legal Implications. | Int J Environ Res Public Health | 2021 | 34948545 | PubTator, text mining | PubMed |
| Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions. | Int J Mol Sci | 2021 | 34948113 | PubTator, text mining | PubMed |
| Early Pregnancy Exposure to Ambient Air Pollution among Late-Onset Preeclamptic Cases Is Associated with Placental DNA Hypomethylation of Specific Genes and Slower Placental Maturation. | Toxics | 2021 | 34941772 | PubTator, text mining | PubMed |
| DNA methylation mediates the association between breastfeeding and early-life growth trajectories. | Clin Epigenetics | 2021 | 34937578 | PubTator, text mining | PubMed |
| miR-15a-3p Protects Against Isoniazid-Induced Liver Injury via Suppressing N-Acetyltransferase 2 Expression. | Front Mol Biosci | 2021 | 34888351 | PubTator, text mining | PubMed |
| Role of CD5L and SRD5A2 as Prognostic Biomarkers for Hepatocellular Carcinoma. | Int J Gen Med | 2021 | 34880664 | PubTator, text mining | PubMed |
| Genetic Polymorphism of Drug Metabolic Gene CYPs, VKORC1, NAT2, DPYD and CHST3 of Five Ethnic Minorities in Heilongjiang Province, Northeast China. | Pharmgenomics Pers Med | 2021 | 34876832 | PubTator, text mining | PubMed |
| Study on the associations between liver damage and antituberculosis drug rifampicin and relative metabolic enzyme gene polymorphisms. | Bioengineered | 2021 | 34872459 | PubTator, text mining | PubMed |
| Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology. | Front Oncol | 2021 | 34868996 | PubTator, text mining | PubMed |
| Novel Assay Platform to Evaluate Intracellular Killing of Mycobacterium tuberculosis: In Vitro and In Vivo Validation. | Front Immunol | 2021 | 34867981 | PubTator, text mining | PubMed |
| VDR Signaling via the Enzyme NAT2 Inhibits Colorectal Cancer Progression. | Front Pharmacol | 2021 | 34867333 | PubTator, text mining | PubMed |
| Personalised Medicine for Tuberculosis and Non-Tuberculous Mycobacterial Pulmonary Disease. | Microorganisms | 2021 | 34835346 | PubTator, text mining | PubMed |
| The Effect of Bisphenol A on the IVF Outcomes Depending on the Polymorphism of the Detoxification System Genes. | J Pers Med | 2021 | 34834443 | PubTator, text mining | PubMed |
| A Systematic Review of Studies on Genotoxicity and Related Biomarkers in Populations Exposed to Pesticides in Mexico. | Toxics | 2021 | 34822663 | PubTator, text mining | PubMed |
| Genetic polymorphism of the drug-metabolizing enzyme Cytochrome P4502E1 (CYP2E1) in a healthy Saudi population. | Saudi Pharm J | 2021 | 34819796 | PubTator, text mining | PubMed |
| Maternal-Fetal Pharmacology of Drugs: A Review of Current Status of the Application of Physiologically Based Pharmacokinetic Models. | Front Pediatr | 2021 | 34805038 | PubTator, text mining | PubMed |
| Genetic Polymorphisms in Pharmaceuticals and Chemotherapy. | World J Oncol | 2021 | 34804277 | PubTator, text mining | PubMed |
| Genetic analysis of pharmacogenomic VIP variants in the Wa population from Yunnan Province of China. | BMC Genom Data | 2021 | 34798807 | PubTator, text mining | PubMed |
| The Impact of Pregnancy on Antihypertensive Drug Metabolism and Pharmacokinetics: Current Status and Future Directions. | Expert Opin Drug Metab Toxicol | 2021 | 34739303 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=29